EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Therapeutic Properties and Underlying Mechanisms of Traditional Chinese Medicine in Managing Rheumatoid Arthritis: An Integrative Review of Clinical and Molecular Findings

Jianting Wen iD, Jian Liu iD, Lei Wan iD, Fanfan Wang iD, Yang Li

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70429 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, 2026. Written by Jianting Wen and 4 co-authors. Institution: Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China. Major MEDLINE topics: Arthritis, Rheumatoid, Drugs, Chinese Herbal, Medicine, Chinese Traditional. 195 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Clinical Research Project of Anhui University of Traditional Chinese Medicine in 2024.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Traditional Chinese medicine (TCM) has a long‐standing history in the treatment of rheumatoid arthritis (RA), known as “Bi Zheng,” and offers a comprehensive therapeutic approach characterized by multi‐target and multi‐pathway mechanisms. Modern pharmacological research has demonstrated that bioactive compounds and herbal formulas derived from TCM (e.g., triptolide [TPL] from Tripterygium wilfordii and the Xinfeng Capsule [XFC]) effectively interfere with the complex pathogenesis of RA. These interventions modulate diverse pathological processes, including the suppression of pro‐inflammatory cytokines (e.g., TNF‐α, IL‐6, and IL‐1β), induction of apoptosis in hyperplastic synovial cells, and regulation of novel cell death pathways (such as ferroptosis and pyroptosis). Furthermore, TCM components exhibit potent antioxidant properties, inhibit pathological angiogenesis, ameliorate hypercoagulable states, and restore gut microbiota dysbiosis, which is increasingly recognized as a key environmental factor in RA development. Notably, emerging evidence highlights the critical role of non‐coding RNAs (ncRNAs) as mediators of these therapeutic effects. Concurrently, a growing body of clinical evidence from randomized controlled trials (RCTs), cohort studies, and real‐world data mining consistently confirms the significant efficacy and safety of TCM interventions in relieving RA symptoms, improving joint function, and reducing disease activity. By integrating preclinical and clinical findings, a robust evidence chain emerges, validating traditional TCM concepts through modern scientific rigor. Therefore, TCM represents a valuable resource for RA drug discovery and integrative treatment strategies. Further in‐depth investigation is needed into its specific molecular targets, optimal formulations, and long‐term clinical outcomes to facilitate its global translation and application.

Subjects

MeSH terms (MEDLINE)

Arthritis, RheumatoidDrugs, Chinese HerbalMedicine, Chinese TraditionalHumansAnimalsTripterygiumCytokinesDiterpenesEpoxy CompoundsPhenanthrenes

Author keywords

clinical studymulti‐target therapyrheumatoid arthritistraditional Chinese medicine

Substances

Drugs, Chinese HerbaltriptolideCytokinesDiterpenesEpoxy CompoundsPhenanthrenes

Authors and institutions

  • Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Institute of Rheumatology, Anhui Academy of Chinese Medicine, Hefei, Anhui, China.
  • Anhui Province Key Laboratory of Modern Chinese Medicine Department of Internal Medicine Application Foundation Research and Development, Hefei, Anhui, China.

ORCID profiles: Jianting Wen, Jian Liu, Lei Wan, Fanfan Wang

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province
  • Clinical Research Project of Anhui University of Traditional Chinese Medicine in 2024
  • Anhui University of Chinese Medicine 2024 Annual University-Level Exploratory Research Project
  • National Key Discipline of Traditional Chinese Medicine-Traditional Chinese Medicine Bi Disease
  • Anhui Provincial Research Project on Traditional Chinese Medicine Inheritance and Innovation

Cite

APA

Wen, J., Liu, J., Wan, L., Wang, F., & Li, Y. (2026). Therapeutic Properties and Underlying Mechanisms of Traditional Chinese Medicine in Managing Rheumatoid Arthritis: An Integrative Review of Clinical and Molecular Findings. Phytotherapy Research. https://doi.org/10.1002/ptr.70429

Vancouver

Wen J, Liu J, Wan L, Wang F, Li Y. Therapeutic Properties and Underlying Mechanisms of Traditional Chinese Medicine in Managing Rheumatoid Arthritis: An Integrative Review of Clinical and Molecular Findings. Phytotherapy Research. 2026. doi:10.1002/ptr.70429

BibTeX
@article{Wen2026,
  author = {Wen, Jianting and Liu, Jian and Wan, Lei and Wang, Fanfan and Li, Yang},
  title = {Therapeutic Properties and Underlying Mechanisms of Traditional Chinese Medicine in Managing Rheumatoid Arthritis: An Integrative Review of Clinical and Molecular Findings},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70429}
}
Start for free →